Thalidomide as Palliative Treatment in Patients with Advanced Secondary Glioblastoma

Publisher： Karger

E-ISSN： 1423-0232|88|3|173-179

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.3, 2014-11, pp. : 173-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Low-Dose Thalidomide Treatment for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 242-249

Karger

Access to resources Recommend Favorite

Preferences of advanced cancer patients for communication on anticancer treatment cessation and the transition to palliative care

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4240-4249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Thalidomide Treatment in Heart Failure Patients

By  

Cardiology, Vol. 108, Iss. 4, 2006-11 ,pp. : 237-242

Karger

Access to resources Recommend Favorite

Home-based specialized palliative care in patients with advanced cancer: A systematic review

By  

Palliative & Supportive Care, Vol. 14, Iss. 6, 2016-07 ,pp. : 713-724

Cambridge University Press

Access to resources Recommend Favorite